L-000124467 ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	1
46	Malignant rheumatoid arthritis	2

13. Multiple sclerosis/Neuromyelitis optica

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-000073-64-FI (EUCTR)	03/09/2004	14/07/2004	A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Assess the Effects of L-000 ...	A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Assess the Effects of L-000 ...	Aaltomainen MS-tauti	Product Code: L-000124467	Merck & Co., Inc./Suomen MSD Oy	NULL	Not Recruiting			Female: yes Male: yes	120	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Finland

Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-000074-31-BE (EUCTR)	15/03/2005	07/07/2004	A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, S ...	A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, S ...	rheumatoid arthritis MedDRA version: 7.0;Level: LLT;Classification code 10039073	Product Name: 1,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3- (trifluoromethyl)-1,6-naphthyri ...	Merck Sharp & Dohme BV	NULL	Not Recruiting			Female: yes Male: yes	150	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Belgium;Sweden
2	EUCTR2004-000074-31-SE (EUCTR)	06/07/2004	21/05/2004	A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, S ...	A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, S ...	rheumatoid arthritis MedDRA version: 7.0;Level: LLT;Classification code 10039073	Product Name: 1,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3- (trifluoromethyl)-1,6-naphthyri ...	Merck Sharp & Dohme (Sweden) AB	NULL	Not Recruiting			Female: yes Male: yes	150		Sweden